logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9561231 B1

PDFFull Text
Date of Patent:
Feb. 07, 2017

Filed:

Mar. 12, 2013

Pyridinone and pyridazinone derivatives

Applicant:

Abbvie Inc., North Chicago, IL (US);

Inventors:

Robert D. Hubbard, San Diego, CA (US);

Le Wang, Vernon Hills, IL (US);

Chang H Park, Wadsworth, IL (US);

Chaohong Sun, Gurnee, IL (US);

Keith F McDaniel, Wauconda, IL (US);

John K Pratt, Kenosha, WI (US);

Todd N Soltwedel, Chicago, IL (US);

Michael D Wendt, Vernon Hills, IL (US);

James H Holms, Gurnee, IL (US);

Dachun Liu, Vernon Hills, IL (US);

George S Sheppard, Wilmette, IL (US);

Assignee:

AbbVie Inc., North Chicago, IL (US);

Attorney:

Glen Gesicki

Primary Examiner:

Timothy R Rozof

Int. Cl.
CPC ...
A61K 31/541 (2006.01); A61K 31/50 (2006.01); A61K 31/4412 (2006.01); A61K 31/501 (2006.01); A61K 31/5377 (2006.01); A61K 45/06 (2006.01); C07D 237/14 (2006.01); C07D 213/64 (2006.01); C07D 401/04 (2006.01); C07D 401/10 (2006.01); C07D 403/04 (2006.01); C07D 403/10 (2006.01); C07D 413/10 (2006.01); C07D 417/10 (2006.01); C07D 403/12 (2006.01); C07D 401/14 (2006.01); C07D 213/74 (2006.01); C07D 213/81 (2006.01); C07D 401/02 (2006.01); C07D 401/12 (2006.01); C07D 407/04 (2006.01); C07D 407/12 (2006.01); C07D 409/04 (2006.01); C07D 417/04 (2006.01); C07D 417/12 (2006.01); C07D 498/04 (2006.01); C07D 213/30 (2006.01); C07D 213/68 (2006.01);
U.S. Cl.
CPC ...
A61K 31/541 (2013.01); A61K 31/4412 (2013.01); A61K 31/50 (2013.01); A61K 31/501 (2013.01); A61K 31/5377 (2013.01); A61K 45/06 (2013.01); C07D 213/30 (2013.01); C07D 213/64 (2013.01); C07D 213/68 (2013.01); C07D 213/74 (2013.01); C07D 213/81 (2013.01); C07D 237/14 (2013.01); C07D 401/02 (2013.01); C07D 401/04 (2013.01); C07D 401/10 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/04 (2013.01); C07D 403/10 (2013.01); C07D 403/12 (2013.01); C07D 407/04 (2013.01); C07D 407/12 (2013.01); C07D 409/04 (2013.01); C07D 413/10 (2013.01); C07D 417/04 (2013.01); C07D 417/10 (2013.01); C07D 417/12 (2013.01); C07D 498/04 (2013.01);
Abstract

The present invention provides for compounds of formula (I) wherein A, A, A, A, J, and Xhave any of the values defined therefor in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, diabetes, obesity, cancer, and AIDS. Also provided are pharmaceutical compositions comprising one or more compounds of formula I.

Find Patent Forward Citations

Loading…